Spotlight on PSMA as a new theranostic biomarker for bladder cancer
Abstract Bladder cancer (BCa) patients are diagnosed by cytology and cystoscopy. However, these diagnostic tests bear some limitations. We sought for reliable biomarkers to better determine BCa extension. Prostate-specific membrane antigen (PSMA) appears to fulfill this requirement in prostate cance...
Saved in:
Main Authors: | Maria Maddalena Tumedei, Sara Ravaioli, Federica Matteucci, Monica Celli, Ugo De Giorgi, Roberta Gunelli, Maurizio Puccetti, Giovanni Paganelli, Sara Bravaccini |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/9e48e4bb4424421c8efc0070bd91a8d6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
by: Andrey Bychkov, et al.
Published: (2017) -
The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects
by: Sara Bravaccini, et al.
Published: (2021) -
PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
by: Maximilian A. Kirchner, et al.
Published: (2021) -
Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
by: Kristin A. Plichta, et al.
Published: (2021) -
Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review
by: Mathieu Gauthé, et al.
Published: (2021)